.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Cerilliant
Argus Health
Citi
McKesson
UBS
Cantor Fitzgerald
Baxter
US Army

Generated: December 12, 2017

DrugPatentWatch Database Preview

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE Drug Profile

« Back to Dashboard

When do Pioglitazone Hydrochloride And Glimepiride patents expire, and when can generic versions of Pioglitazone Hydrochloride And Glimepiride launch?

Pioglitazone Hydrochloride And Glimepiride is a drug marketed by Sandoz and is included in one NDA.

The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is glimepiride; pioglitazone hydrochloride. There are fourteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
SandozPIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDEglimepiride; pioglitazone hydrochlorideTABLET;ORAL201049-001Jan 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozPIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDEglimepiride; pioglitazone hydrochlorideTABLET;ORAL201049-002Jan 4, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Teva
Cerilliant
Deloitte
Citi
Queensland Health
Argus Health
Cipla
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot